Your browser doesn't support javascript.
loading
Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.
Watkins, B A; Buge, S; Aldrich, K; Davis, A E; Robinson, J; Reitz, M S; Robert-Guroff, M.
Afiliación
  • Watkins BA; Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland 20892, USA.
J Virol ; 70(12): 8431-7, 1996 Dec.
Article en En | MEDLINE | ID: mdl-8970964
ABSTRACT
The ability of human immunodeficiency virus type 1 (HIV-1) to replicate in the presence of strong immune responses to the virus may be due to its high mutation rate, which provides envelope gene variability for selection of neutralization-resistant variants. Understanding neutralization escape mechanisms is therefore important for the design of HIV-1 vaccines and our understanding of the disease process. In this report, we analyze mutations at amino acid positions 281 and 582 in the HIV-1 envelope, where substitutions confer resistance to broadly reactive neutralizing antisera from seropositive individuals. Neither of these mutations lies within an antibody-binding site, and therefore the mechanism of immune escape in both cases is by alteration of the shape of the envelope proteins. The conformation of the CD4-binding site is shown to be critical with regard to presentation of other discontinuous epitopes. From our analysis of the neutralization of these variants, we conclude that escape from polyclonal sera occurs through alterations at several different epitopes, generally resulting from single amino acid substitutions which influence envelope conformation. Experiments on a double mutant showed that the combination of both mutations is not additive, suggesting that these variants utilized alternate pathways to elicit similar alterations of the HIV-1 envelope structure.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Antígenos VIH / Proteína gp41 de Envoltorio del VIH / Proteína gp120 de Envoltorio del VIH / Infecciones por VIH / VIH-1 / Epítopos Límite: Animals / Humans Idioma: En Revista: J Virol Año: 1996 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Anti-VIH / Antígenos VIH / Proteína gp41 de Envoltorio del VIH / Proteína gp120 de Envoltorio del VIH / Infecciones por VIH / VIH-1 / Epítopos Límite: Animals / Humans Idioma: En Revista: J Virol Año: 1996 Tipo del documento: Article País de afiliación: Estados Unidos